BioHealth News
Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T®
GERMANTOWN, Md., April 3, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives…
Read More
Deka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of DK210 (EGFR)
GERMANTOWN, Md., April 5, 2023 /PRNewswire/ -- Deka Biosciences ("Deka"), a clinical-stage biotechnology company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases,…
Read More
Commission Appoints Ruchika Nijhara as Executive Director of the Maryland Stem Cell Research Fund (MSCRF) | TEDCO
COLUMBIA, Md. (April 4, 2023) – The Maryland Stem Cell Research Commission announces the appointment of Ruchika Nijhara, Ph.D., MBA, as executive director of…
Read More
The National Cancer Plan: An Ambitious Mission to End Cancer as We Know It
April 3, 2023 - The battle against Cancer has long been a collective effort, with advances in treatment and prevention made possible through the…
Read More
Medcura Advancing Hemostat Innovation and Fostering Growth in the BioHealth Capital Region
April 3, 2023 - Medcura, Inc., a life science and medical device company based in Riverdale, MD, is experiencing substantial growth in the BioHealth…
Read More
UMD I-Corps: Upcoming Workshop Dates
The regional UMD I-Corps Customer Discovery Workshops introduce teams and individuals with innovations to the concepts of business models and customer discovery. UMD offers…
Read More
Venable LLP Expands with Venable Blue | About | Venable LLP
Venable LLP today introduced Venable Blue, a legal and consulting service that helps clients protect their reputation and manage risk online. The service helps…
Read More
Unlocking a New Era of Healing: Protein Engineering’s Transformative Impact on Therapeutics – BioTalk Welcomes Dr. Luis Alvarez of Frederick MD’s Theradaptive
How will protein engineering unleash a new era of therapeutic possibilities for BioHealth and the BioHealth Capital Region? Join us on this episode of…
Read More
Virginia Tech Corporate Research Center Announces First Companies Selected for JLABS Virtual Residency
BLACKSBURG, Va. (March 28, 2023) – The Virginia Tech Corporate Research Center (VTCRC) announced today that three companies have been selected to join Johnson &…
Read More
In groundbreaking research, Tel Aviv U team records plants ‘talking’ for first time | The Times of Israel
It has been known for some time that plants communicate with one another, but Israeli scientists now say they’ve identified “words,” and have found…
Read More
The AI genie is out of the bottle: Should it be crammed back inside?
By Tom Still MADISON, Wis. -- Society has been here many times before. A little more than 200 years ago, a group of English…
Read More
TEDCO’s Maryland Innovation Initiative Announced Recent Investments
$600,000 invested into 3 new ventures and $1.6Million awarded to 12 project grants COLUMBIA, Md. (March 29, 2023) – TEDCO, Maryland’s economic engine for technology…
Read More
From Serbia and China to College Park – Maryland Today
When husband and wife Zairen Sun Ph.D. ’98 and Beibei Li Ph.D. ’98 arrived in College Park from China in 1992, they had little…
Read More
U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
NARCAN® Naloxone HCl Nasal Spray 4 mg is currently the first and only prescription strength naloxone nasal spray to receive over-the-counter status in the U.S., which…
Read More
Gaithersburg’s Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates
MARCH 28, 2023 - GAITHERSBURG, Md., (BUSINESS WIRE) -- Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex…
Read More